Week 11 - L3 - Bioinformatic Prediction and Experimental Validation of Post-Translational Modifications
Overview of Post-Translational Modification Databases
Online biological databases curate comprehensive information on post-translational modifications (PTMs) across thousands of proteins, compiled from years of experimental research.
These digital repositories enable the characterization of biochemical alterations that occur on a nascent polypeptide chain following protein synthesis.
Databases range from broad repositories cataloging holistic protein functional data to specialized platforms concentrating on specific chemical modifications, such as phosphorylation.
UniProt Database Architecture and Applications
Primary Repository Characteristics:
UniProt serves as one of the most foundational and comprehensive databases in protein science, cataloging thousands of individual proteins.
It synthesizes and summarizes all available empirical information regarding protein sequence, structure, and functional characteristics.
The resource has been in active development and continuously upgraded since approximately the year .
PTM Query Capabilities:
Users can search virtually any target protein to extract known literature and experimental data.
Specific database partitions provide detailed annotations on diverse post-translational modification sites identified across the protein sequence.
While UniProt provides a broad macro-level overview, specialized databases are required to interrogate distinct modification classes in high detail.
PhosphoSite Plus Features and Functional Analysis
Specialized Scope:
PhosphoSite Plus (also referenced as PhosphoCyte Plus) focuses specifically on protein phosphorylation and cataloging phosphoproteins across cellular systems.
The database houses an expanding registry approaching annotated post-translational modifications.
Access is open access, continuously curated, and interactive, delivering high-level systems biology annotations for experimentally verified PTMs.
Breadth of Modifications Cataloged:
While specialized for phosphorylation profiling, the resource annotates multiple other modification types, including:
Acetylation
Methylation
Ubiquitination
Glycosylation
Sequence Visualization Features:
Querying a protein of interest generates a linear sequence diagram.
The horizontal axis (-axis) plots individual residue numbers corresponding to specific amino acid positions along the polypeptide backbone.
Annotations situated above the sequence identify empirical sites of phosphorylation and other modifications.
Integration with Structural and Biological Metadata:
Structural topology (such as membrane orientation and transmembrane organization).
Biological function and molecular activity.
Regulatory significance and signaling roles of identified modification sites.
Biological context, cellular regulation, tissue-specific expressions, disease states, subcellular localizations, structural domains, and functional motifs.
Case Study: HER2 Topology and Phosphorylation Profiling
Clinical Relevance:
HER2 (Human Epidermal Growth Factor Receptor 2) is a well-established oncoprotein heavily implicated in the pathogenesis of breast cancer.
Structural Domain Organization:
Extracellular Domain: Extends into the extracellular environment.
Transmembrane Domain: Spans the lipid bilayer of the plasma membrane.
Cytosolic (Intracellular) Domain: Comprises the carboxyl terminus (-terminus) located inside the cytoplasm.
Modification Mapping:
PhosphoSite Plus sequence mapping demonstrates an extensive cluster of phosphorylation sites concentrated on the -terminus of HER2.
The spatial localization of these phosphorylation events on the intracellular cytosolic domain enables them to engage and modulate intracellular downstream signaling cascades.
Evolutionary Conservation and Disease Associations of Modification Sites
Evolutionary Cross-Species Conservation:
Query tabs within PhosphoSite Plus allow researchers to evaluate the evolutionary conservation of specific PTM residues across mammalian species and broader taxa.
High Conservation: Modification sites preserved across divergent phylogenetic lineages strongly suggest that the modification is essential for the protein to carry out its core physiological function.
Low Conservation: Modification sites restricted to specific lineages or individual organisms indicate organism-specific adaptations or specialized regulatory mechanisms.
Oncogenic and Pathological Linkages:
Database annotations connect specific residue modifications to cancer phenotypes.
Profiling tools assess how post-translational changes or sequence alterations at modification sites contribute to malignant transformation and tumor progression.
Identifies candidate regulatory sites to prioritize for detailed functional and mechanistic validation.
Deep Learning and Predictive Bioinformatics: MuCiteDape
Machine Learning Landscape:
Emerging bioinformatics tools utilize deep learning architectures to predict putative post-translational modification sites.
These predictive algorithms integrate multi-omic and structural datasets and represent a modern, rapidly growing domain within computational proteomics.
Predictive Pipeline using MuCiteDape:
Database Selection: MuCiteDape is a specialized predictive platform for post-translational modification mapping.
Parameter Input: Users specify the target modification type of interest (e.g., phosphorylation, glycosylation, or ubiquitination).
Query Submission: The primary amino acid sequence of the target protein is input into the platform.
Algorithmic Output: The model evaluates sequence contexts to predict probability scores for modifications occurring at discrete amino acid residues.
Limitations of Computational Prediction:
Outputs represent theoretical predictions rather than empirical biological facts.
Predicted modifications may not occur within native proteins inside living cells.
Unannotated, newly predicted sites strictly necessitate downstream benchtop experimental validation.
Experimental Validation Strategies for Predicted Modifications
Proteomic Characterization via Mass Spectrometry:
Proteomics and mass spectrometry serve as standard techniques to identify whether a physical mass shift corresponding to a predicted PTM exists on the endogenous or purified protein extracted from cellular models.
Site-Directed Mutagenesis:
Procedure: The target residue predicted to undergo modification is genetically mutated into an amino acid that cannot accept the chemical group (e.g., mutating a serine/threonine to an alanine to prevent phosphorylation).
Downstream Functional Assays:
Signal Transduction: Evaluating whether the non-modifiable mutant preserves signaling competence within designated signaling pathways.
Protein-Protein Interactions: Assessing whether loss of the modification disrupts or alters binding affinities with regulatory partners.
Phenotypic Impact: Monitoring whole-cell phenotypic changes induced by the loss of the functional post-translational modification site.